Download PDF
1 / Pages

Other users also viewed these articles

Morbid obesity and dyslipidaemia: The impact of bariatric surgery Elisenda Climent; David Benaiges; Albert Goday; Montserrat Villatoro; Helena Julià; José M. Ramón; Juana A. Flores; Juan Pedro-Botet;
Clin Investig Arterioscler. 2020;32:79-86
The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis Jose A. Quesada; Vicente Bertomeu-González; Domingo Orozco-Beltrán; Alberto Cordero; Vicente F. Gil-Guillén; Adriana López-Pineda; Rauf Nouni-García; Concepción Carratalá-Munuera;
Clin Investig Arterioscler. 2023;35:165-77
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias Juan Pedro-Botet; Juan F. Ascaso; Mariano Blasco; Ángel Brea; Ángel Díaz; Antonio Hernández-Mijares; Xavier Pintó; Jesús Millán;
Clin Investig Arterioscler. 2020;32:209-18